Chris Freeman, Chief Commercial Officer at Guardant Health, Inc. (GH), sold 24,406 shares at $118.67 ($2.9M) on 2026-05-22, disclosed to the SEC on 2026-05-26.
Open-market sale of $2.9M GH by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |